Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
Myrthe A. M. van Delft(Leiden University Medical Center), Marjolein van Egmond(Amsterdam University Medical Centers)
Cited by 12
Related Papers
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
|Journal of Clinical Investigation|2021|59
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
|Cancers|2022|35
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
|Arthritis Research & Therapy|2017|27
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
|International Journal of Molecular Sciences|2022|6